Rating Change
HC Wainwright & Co. reiterated its Buy rating on Rein Therapeutics Inc. (NASDAQ:RNTX) on August 18, 2026.
reiterateNASDAQ:RNTX
HC Wainwright & Co. Reiterates Buy Rating on Rein Therapeutics Inc. (RNTX)
HC Wainwright & Co. reiterated its Buy rating on Rein Therapeutics Inc.
At publication ·
What changed
Rein Therapeutics Inc. (NASDAQ:RNTX) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $0.80
- Market capitalization
- $40.2M
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on Rein Therapeutics Inc. (RNTX) on August 18, 2026, with the stock trading at $0.80 and a market capitalization of $40.2 million.
Market Context
Rein Therapeutics Inc. operates in the Healthcare sector. The stock currently trades at $0.80 with a market capitalization of $40.2M.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Rein Therapeutics Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Rein Therapeutics Inc.
Among the 6 most recent ratings: 4 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 18, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 20, 2026 | Maxim Group | Buy | N/A |
| Jun 01, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jan 21, 2026 | Brookline Capital | Hold | N/A |
| Sep 22, 2025 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View RNTX Stock Page
Frequently Asked Questions
What does the Buy rating mean for RNTX?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Rein Therapeutics Inc. (NASDAQ:RNTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RNTX forecast page.